Insider Buying: Concentrix (NASDAQ:CNXC) CEO Purchases $21,250.00 in Stock

Concentrix Corporation (NASDAQ:CNXC) CEO Christopher Caldwell acquired 1,000 shares of Concentrix stock in a transaction on Wednesday, July 8th. The shares were bought at an average cost of $21.25 per share, with a total value of $21,250.00. Following the completion of the transaction, the chief executive officer owned 358,382 shares of the company’s stock, valued at approximately $7,615,617.50. This trade represents a 0.28% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Concentrix Stock Performance

Shares of CNXC traded up $1.23 during trading hours on Friday, hitting $22.20. The company had a trading volume of 1,789,629 shares, compared to its average volume of 2,544,325. The firm has a market cap of $1.35 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 0.41 and a beta of 0.47. The business has a fifty day moving average of $25.01 and a 200-day moving average of $31.06. Concentrix Corporation has a 12 month low of $19.12 and a 12 month high of $62.14. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. During the same quarter last year, the company posted $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Equities analysts anticipate that Concentrix Corporation will post 9.67 EPS for the current fiscal year.

Concentrix Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 6.5%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s dividend payout ratio is currently -6.75%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada increased its position in Concentrix by 9.5% during the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after purchasing an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after buying an additional 21,746 shares in the last quarter. Focus Partners Wealth bought a new stake in shares of Concentrix during the first quarter worth $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares in the last quarter. Institutional investors own 90.34% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on CNXC. Zacks Research cut shares of Concentrix from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 2nd. Wall Street Zen downgraded Concentrix from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Bank of America lowered their price objective on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 30th. Canaccord Genuity Group cut their target price on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a research report on Tuesday, June 30th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Concentrix currently has a consensus rating of “Hold” and a consensus price target of $32.75.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.